StockData
Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc (SNDX) stock

SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 3/30
$8.56−0.64 (-6.96%)

Close on Nov 18, 2026Market cap $764.38MP/E –Yield –

Syndax Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Syndax Pharmaceuticals's pe ratio was 72.4× on Jul 29, 2022, against 4.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 202272.4×+54.7
2019Oct 31, 201917.7×+14.5
2018Dec 31, 20183.2×–

More Syndax Pharmaceuticals figures

See a number that looks wrong?